Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.
Hirase S, Saitoh A, Hartomo TB, Kozaki A, Yanai T, Hasegawa D, Kawasaki K, Kosaka Y, Matsuo M, Yamamoto N, Mori T, Hayakawa A, Iijima K, Nishio H, Nishimura N.
Hirase S, et al. Among authors: matsuo m.
Oncol Lett. 2016 Aug;12(2):1119-1123. doi: 10.3892/ol.2016.4682. Epub 2016 Jun 7.
Oncol Lett. 2016.
PMID: 27446404
Free PMC article.